Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 7, 2014, Pages 479-488

  Kubo, Shoji ^a   Nakanuma, Yasuni ^b   Takemura, Shigekazu ^a   Sakata, Chikaharu ^a   Urata, Yorihisa ^a   Nozawa, Akinori ^a   Nishioka, Takayoshi ^a   Kinoshita, Masahiko ^a   Hamano, Genya ^a   Terajima, Hiroaki ^c   Tachiyama, Gorou ^d   Matsumura, Yuji ^e   Yamada, Terumasa ^f   Tanaka, Hiromu ^g   Nakamori, Shoji ^h   Arimoto, Akira ⁱ   Kawada, Norifumi ^a   Fujikawa, Masahiro ^j   Fujishima, Hiromitsu ^k   Sugawara, Yasuhiko ^l   Tanaka, Shogo ^m   Toyokawa, Hideyoshi ⁿ   Kuwae, Yuko ^a   Ohsawa, Masahiko ^a   Uehara, Shinichiro ^a   Sato, Kyoko Kogawa ^a   Hayashi, Tomoshige ^a   Endo, Ginji ^a   more..

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c Kitano Hospital   (Japan)

^d Tane General Hospital   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

^f OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^g Higashisumiyoshi Morimoto Hospital   (Japan)

^h OSAKA NATIONAL HOSPITAL   (Japan)

ⁱ OSAKA RED CROSS HOSPITAL   (Japan)

^j Nissei Hospital   (Japan)

^k NATIONAL HOSPITAL ORGANIZATION KAGOSHIMA MEDICAL CENTER   (Japan)

^l UNIVERSITY OF TOKYO   (Japan)

^m Ishikiriseiki Hospital   (Japan)

ⁿ KANSAI MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Biliary intraepithelial neoplasia; Cholangiocarcinoma; Intraductal papillary neoplasm of the bile duct; Organic solvent; Printing company

Indexed keywords

1,2 DICHLOROPROPANE; DICHLOROMETHANE; FLUOROURACIL; GAMMA GLUTAMYLTRANSFERASE; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; ORGANIC COMPOUND; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BILE DUCT CANCER; BILE DUCT CARCINOMA; BILE DUCT DILATATION; BILE DUCT INJURY; BILIARY INTRAEPITHELIAL NEOPLASIA; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC IMAGING; ENZYME ACTIVITY; FIBROSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HOSPITAL; HUMAN; HUMAN TISSUE; INCIDENCE; INDUSTRIAL WORKER; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INTRAHEPATIC BILE DUCT; JAPAN; MALE; PRINTING; RETROSPECTIVE STUDY; YOUNG ADULT; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CLINICAL TRIAL; EPIDEMIC; FEMALE; HEPATIC DUCT; MIDDLE AGED; MULTICENTER STUDY; OCCUPATIONAL DISEASES; PATHOLOGY; PRECANCEROUS CONDITIONS;

ADULT; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; PRECANCEROUS CONDITIONS; PRINTING; RETROSPECTIVE STUDIES;

EID: 84896515988     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.86     Document Type: Article

References (26)

1. World Health Organization Classifications of Tumours: International Agency for Research on Cancer (IARC). 4th edn. WHO classification of tumours of the digestive system., Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. Lyon: World Health Organization Classifications of Tumours: International Agency for Research on Cancer (IARC); 2010. p. 195-278.
2. Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V,. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prevention. 1993; 2: 537-544.
3. Shaib Y, El-Serag HB,. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004; 24: 115-125.
4. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson AD,. Cholangiocarcinoma. Lancet. 2005; 366: 1303-1314.
5. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th mationwaide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007; 27: 676-691.
6. Miyagawa S, Ishihara S, Horiguchi S, Takada T, Miyazaki M, Nagakawa T,. Biliary tract cancer treatment: 5,584 results from the biliary tract cancer statistics registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg. 2009; 16: 1-7.
7. Khan SA, Toledano MB, Taylor-Robinson SD,. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008; 10: 77-82.
8. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA,. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005; 128: 620-626.
9. Kumagai S, Kurumatani N, Arimoto A, Ichihara G,. Cholagiocarcinoma among offset colour proof-printing workers exposed to 1,2-dichloropropane and/or dichloromethane. Occup Environ Med. 2013; 70: 508-510.
10. Zen Y, Sasaki M, Fujii T, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct-an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol. 2006; 44: 350-358.
11. Zen Y, Adsay NV, Bardadin K, et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 2007; 20: 701-709.
12. Itatsu K, Zen Y, Ohira S, et al. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int. 2007; 27: 1174-1184.
13. Lelbach WK,. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci. 1975; 252: 85-105.
14. Vitellas KM, Keogan MT, Freed KS, et al. Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. RadioGraphics. 2000; 20: 959-975.
15. Nakanuma Y, Hoso M, Sanzen T, Sasaki M,. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech. 1997; 38: 552-570.
16. Kubo S, Kinoshita H, Hirohashi K, Hamba H,. Hepatolithiasis associated with cholangiocarcinoma. World J Surg. 1995; 19: 637-641.
17. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD,. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroentrol. 2004; 99: 523-526.
18. Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001; 34: 651-658.
19. Watanapa P, Watanapa WB,. Liver fluke-associated cholangiocarcinoma. Br J Surg. 2002; 89: 962-970.
20. Ikeda A, Miyashiro I, Nakayama T, Ioka A, Tabuchi T, Ito Y, et al. Descriptive epidemiology of bile duct carcinoma in Osaka. Jpn J Clin Oncol. 2013; 43: 1150-1155.
21. Yamamoto S, Kubo S, Hai S, et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci. 2004; 95: 592-595.
22. Tyson GL, El-Serag HB,. Risk factors for cholangiocarcinoma. Hepatology. 2011; 54: 173-184.
23. IARC (International Agency for Research on Cancer). List of classification by cancer sites with sufficient or limited evidence in humans, Volume 1 to 105. 2012. http://monographs.iarc.fr/ENG/Classification/index.php
24. National Institute of Occupational Safety and Health, Japan. Industrial accident in a printing company in Osaka [in Japanese]. Report A-2012-02, 2012. http://www.mhlw.go.jp/stf/houdou/2r9852000002ioeh-att/2r9852000002ioik.pdf
25. United Nations Economic Commission for Europe. Chapter 3.6: carcinogenicity, part 3: health hazards. Globally harmonized system of classification and labeling of chemicals (GHS). Third revised edition. 2009. http://www.unece.org/trans/danger/publi/ghs/ghs-rev03/03files-e.html
26. Ministry of Health, Labour and Welfare: occupational biliary tract cancer cases in Japan. 2013. http://www.mhlw.go.jp/english/policy/employ-labour/ labour-standards/Occupational.html